How has Genmab A/S EBIT Margin changed compared to the previous year?

EBIT Margin (Operating Margin) of Genmab A/S changed from 32.89 % to 34.09 %, representing a 3.65% change. The value is higher than the previous year.

How has Genmab A/S EBIT Margin developed historically?

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

What is the Genmab A/S EBIT Margin?

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

What is a good EBIT Margin?

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Genmab A/S with sector peers and the industry average to assess whether it is attractive.

How does Genmab A/S EBIT Margin compare to the industry average?

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Genmab A/S EBIT Margin

GMAB.CO

The EBIT Margin (Operating Margin) of Genmab A/S (GMAB.CO) as of Jul 22, 2026 is 34.09 %. In the previous year, EBIT Margin (Operating Margin) was 32.89 % — a change of 3.65% (higher).

Get this data via API

Financial Data API

EBIT Margin

34.09 %

YoY

3.65%

Last updated: Jul 22, 2026

EBIT Margin (Operating Margin) of Genmab A/S is 2026 34.09 % . EBIT Margin (Operating Margin) of Genmab A/S was 2025 32.89 % . It decreases by 3.65% higher compared to the previous year.

For Genmab A/S, the operating (EBIT) margin of 34.1% is broadly stable versus 35.1% a few years ago.

Access this data via the Eulerpool API

Docs Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

EBIT Margin (Operating Margin) of Genmab A/S is 34.09 % in 2026.

Access this data via the Eulerpool API

Docs Get Free API Key

Margins — Genmab A/S

Gross Margin EBIT Margin EBITDA Margin Net Margin FCF Margin R&D / Revenue Tax Rate Payout Ratio Pre-Tax Margin OCF Margin SGA/Revenue OpEx/Revenue Reinvestment Rate

Genmab A/S EBIT Margin

Genmab A/S Stock analysis

Frequently Asked Questions about Genmab A/S stock

What is the Genmab A/S EBIT Margin 2026?

How has Genmab A/S EBIT Margin changed compared to the previous year?

How has Genmab A/S EBIT Margin developed historically?

What is the Genmab A/S EBIT Margin?

What is a good EBIT Margin?

How does Genmab A/S EBIT Margin compare to the industry average?

Margins — Genmab A/S

All Key Metrics — Genmab A/S

Valuation

Income Statement

Margins

Balance Sheet

Cash Flow

Profitability

Leverage

Growth

Dividend

Workforce

Quality

Other